参考文献/References:
[1] Tincani A,Rebaioli CB,Taglietti M,et al. Heart involvement in systemic lupus erythematosus,anti-phospholipid syndrome and neonatal lupus[J]. Rheumatology (Oxford),2006,45 (Suppl 4):iv8-iv13.
[2] Doria A,Iaccarino L,Sarzi-Puttini P,et al. Cardiac involvement in systemic lupus erythematosus[J]. Lupus,2005,14(9):683-686.
[3] Mavrogeni S,Koutsogeorgopoulou L,Dimitroulas T,et al. Complementary role of cardiovascular imaging and laboratory indices in early detection of cardiovascular disease in systemic lupus erythematosus[J]. Lupus,2017,26(3):227-236.
[4] Knockaert DC. Cardiac involvement in systemic inflammatory diseases[J]. Eur Heart J,2007,28(15):1797-1804.
[5] Puntmann VO,DCruz D,Smith Z,et al. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus[J]. Circ Cardiovasc Imaging,2013,6(2):295-301.
[6] Varma N,Hinojar R,DCruz D,et al. Coronary vessel wall contrast enhancement imaging as a potential direct marker of coronary involvement:integration of findings from CAD and SLE patients[J]. JACC Cardiovasc Imaging,2014,7(8):762-770.
[7] Zhang Y,Corona-Villalobos CP,Kiani AN,et al. Myocardial T2 mapping by cardiovascular magnetic resonance reveals subclinical myocardial inflammation in patients with systemic lupus erythematosus[J]. Int J Cardiovasc Imaging,2015,31(2):389-397.
[8] Wu R,An DA,Hu J,et al. The apparent diffusion coefficient is strongly correlated with extracellular volume,a measure of myocardial fibrosis,and subclinical cardiomyopathy in patients with systemic lupus erythematosus[J]. Acta Radiol,2018,59(3):287-295.
[9] Nazir SA,Shetye AM,Khan JN,et al. Inter-study repeatability of circumferential strain and diastolic strain rate by CMR tagging,feature tracking and tissue tracking in ST-segment elevation myocardial infarction[J]. Int J Cardiovasc Imaging,2020,36(6):1133-1146.
[10] Scatteia A,Baritussio A,Bucciarelli-Ducci C. Strain imaging using cardiac magnetic resonance[J]. Heart Fail Rev,2017,22(4):465-476.
[11] Smiseth OA,Torp H,Opdahl A,et al. Myocardial strain imaging:how useful is it in clinical decision making? [J]. Eur Heart J,2016,37(15):1196-1207.
[12] 沈佳燕,冯泽豪,武睿等. 系统性红斑狼疮心肌应变与心肌延迟强化的相关性[J]. 中国医学影像学杂志,2019,27(5):321-327.
[13] Wu R,Shi RY,An DAL,et al. Biventricular tissue tracking demonstrating associations between left ventricular myocardial extracellular volume,pulmonary artery pressure,and reduced right ventricular ejection fraction in patients with systemic lupus erythematosus using cardiovascular MRI[J]. Clin Radiol,2020,75(3):237.e17-237.e25.
[14] Guo Q,Wu LM,Wang Z,et al. Early Detection of silent myocardial impairment in drug-naive patients with new-onset systemic lupus erythematosus: a three-center prospective study [J]. Arthritis Rheumatol,2018,70(12):2014-2024.
[15] Lagan J,Schmitt M,Miller CA. Clinical applications of multi-parametric CMR in myocarditis and systemic inflammatory diseases[J]. Int J Cardiovasc Imaging,2018,34(1):35-54.
[16] Ferreira VM,Schulz-Menger J,Holmvang G,et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation:expert recommendations[J]. J Am Coll Cardiol,2018,72(24):3158-3176.
[17] Mavrogeni S,Bratis K,Markussis V,et al. The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus.Differentiation from viral myocarditis[J]. Lupus,2013,22(1):34-43.
[18] Mavrogeni S,Koutsogeorgopoulou L,Markousis-Mavrogenis G,et al. Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus[J]. Lupus,2018,27(4):564-571.
[19] Seneviratne MG,Grieve SM,Figtree GA,et al. Prevalence,distribution and clinical correlates of myocardial fibrosis in systemic lupus erythematosus:a cardiac magnetic resonance study[J]. Lupus,2016,25(6):573-581.
[20] ONeill SG,Woldman S,Bailliard F,et al. Cardiac magnetic resonance imaging in patients with systemic lupus erythematosus[J]. Ann Rheum Dis,2009,68(9):1478-1481.
[21] Mavrogeni S,Karabela G,Stavropoulos E,et al. Heart failure imaging patterns in systemic lupus erythematosus. Evaluation using cardiovascular magnetic resonance[J]. Int J Cardiol,2014,176(2):559-561.
[22] Kobayashi H,Giles JT,Arinuma Y,et al. Cardiac magnetic resonance imaging abnormalities in patients with systemic lupus erythematosus: a preliminary report [J]. Mod Rheumatol,2010,20(3):319-323.
[23] Messroghli DR,Moon JC,Ferreira VM,et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1,T2,T2* and extracellular volume:a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)[J]. J Cardiovasc Magn Reson,2017,19(1):75.
[24] de Meester de Ravenstein C,Bouzin C,Lazam S,et al. Histological validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T [J]. J Cardiovasc Magn Reson,2015,17(1):48.
[25] Ferreira VM,Piechnik SK,DallArmellina E,et al. T1 Mapping for the Diagnosis of Acute Myocarditis Using CMR Comparison to T2-Weighted and Late Gadolinium Enhanced Imaging[J]. JACC Cardiovasc Imaging,2013,6(10):1048-1058.
[26] Mavrogeni S,Markousis-Mavrogenis G,Koutsogeorgopoulou L,et al. Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment na?ve patients with connective tissue diseases[J]. Int J Cardiol,2017,236:151-156.
[27] Winau L,Hinojar Baydes R,Braner A,et al. High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus[J]. Ann Rheum Dis,2018,77(11):1590-1598.
[28] Hinojar R,Foote L,Sangle S,et al. Native T1 and T2 mapping by CMR in lupus myocarditis:Disease recognition and response to treatment[J]. Int J Cardiol,2016,222:717-726.
[29] Ishimori ML,Martin R,Berman DS,et al. Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus[J]. JACC Cardiovasc Imaging,2011,4(1):27-33.
[30] Shaw JL,Ishimori ML,Sandhu V,et al. Myocardial tissue characteriation with native myocardial T1 mapping in SLE patients with chest pain[J]. J Cardiovasc Magn Reson,2016,18(Suppl 1):W25.
[31] Burkard T,Trendelenburg M,Daikeler T,et al. The heart in systemic lupus erythematosus—A comprehensive approach by cardiovascular magnetic resonance tomography[J]. PLoS One,2018,13(10):e0202105.
[32] du Toit R,Herbst PG,Ackerman C,et al. Myocardial injury in systemic lupus erythematosus according to cardiac magnetic resonance tissue characterization:clinical and echocardiographic features[J]. Lupus,2020,29(11):1461-1468.
相似文献/References:
[1]郭彩艳 靳春荣.腺苷药物在心血管疾病诊治中的应用进展[J].心血管病学进展,2019,(7):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
GUO CaiyanJIN Chunrong.Progress in the Application of Adenosine Drugs in the Diagnosis and Treatment of Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(8):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
[2]吴洋.左室心肌致密化不全的心脏磁共振诊断[J].心血管病学进展,2019,(5):673.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.004]
WU Yang.Diagnosis of Left Ventricular Non-compaction Cardiomyopathy With Cardiac Magnetic Resonance Imaging[J].Advances in Cardiovascular Diseases,2019,(8):673.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.004]
[3]徐源蔚 陈玉成.心脏磁共振在检测自身免疫性风湿疾病心脏受累中的应用进展[J].心血管病学进展,2019,(5):676.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.005]
XU Yuanwei,CHEN Yucheng.Advances in the Application of Cardiac Magnetic Resonance in Detecting Cardiac Involvement in Autoimmune Rheumatic Disease[J].Advances in Cardiovascular Diseases,2019,(8):676.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.005]
[4]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(8):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[5]冯泽豪 姜萌 卜军.心脏磁共振评价化疗所致心肌损伤的研究进展[J].心血管病学进展,2019,(5):667.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.003]
FENG Zehao,JIANG Meng,PU Jun.Cardiovascular Magnetic Resonance for Detection of Myocardial Impairments Caused by Chemotherapy[J].Advances in Cardiovascular Diseases,2019,(8):667.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.003]
[6]徐学萍 汪汉 蔡琳.结缔组织病相关心脏瓣膜病[J].心血管病学进展,2019,(9):1267.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.021]
XU Xueping,WANG Han,CAI Lin.Connective Tissue Disease-associated Valvular Heart Disease[J].Advances in Cardiovascular Diseases,2019,(8):1267.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.021]
[7]秦莉,张艺文,杨晓倩,等.系统性红斑狼疮合并心力衰竭的危险因素及管理[J].心血管病学进展,2020,(3):264.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.012]
QIN Li,ZHANG Yiwen,YANG Xiaoqian,et al.Risk Factors and Management of Heart Failure in Systemic Lupus Erythematosus[J].Advances in Cardiovascular Diseases,2020,(8):264.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.012]
[8]秦莉 张艺文 杨晓倩 王燕凤 汪汉.系统性红斑狼疮合并心力衰竭的发病机制及病因[J].心血管病学进展,2020,(4):381.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.013]
QIN Li,ZHANG Yiwen,YANG Xiaoqian,et al.The Pathogenesis and Etiology of Heart Failure in Systemic lupus Erythematosus[J].Advances in Cardiovascular Diseases,2020,(8):381.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.013]
[9]张艺文 汪汉 秦莉 杨晓倩 童兰 蔡琳.狼疮患者冠心病的诊断、风险评估和治疗[J].心血管病学进展,2020,(5):513.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.017]
ZHANG Yiwen,WANG Han,QIN Li,et al.Diagnosis, Risk Evaluation and Therapy of Coronary Heart Disease in Lupus Patients[J].Advances in Cardiovascular Diseases,2020,(8):513.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.017]
[10]金荣杰 徐勇 邓珏琳 沈明志.应用心脏磁共振评估前列地尔对ST段抬高型心肌梗死患者心肌灌注的影响[J].心血管病学进展,2020,(10):1096.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.023]
JIN RongjieXU YongDENG JuelinSHEN Mingzhi.Effect of Alprostadil on Myocardial Perfusion of Patients with ST Segment Elevation Myocardial Infarction Directly Receiving Percutaneous Coronary Intervention Assessed with Cardiac Magnetic Resonance[J].Advances in Cardiovascular Diseases,2020,(8):1096.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.023]